123 related articles for article (PubMed ID: 31545969)
1. Improving Eflornithine Oral Bioavailability and Brain Uptake by Modulating Intercellular Junctions With an E-cadherin Peptide.
Yang S; Chen Y; Feng M; Rodriguez L; Wu JQ; Wang MZ
J Pharm Sci; 2019 Dec; 108(12):3870-3878. PubMed ID: 31545969
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of drug absorption through the blood-brain barrier and inhibition of intercellular tight junction resealing by E-cadherin peptides.
Kiptoo P; Sinaga E; Calcagno AM; Zhao H; Kobayashi N; Tambunan US; Siahaan TJ
Mol Pharm; 2011 Feb; 8(1):239-49. PubMed ID: 21128658
[TBL] [Abstract][Full Text] [Related]
3. Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability.
Laksitorini MD; Kiptoo PK; On NH; Thliveris JA; Miller DW; Siahaan TJ
J Pharm Sci; 2015 Mar; 104(3):1065-75. PubMed ID: 25640479
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.
Alaofi A; On N; Kiptoo P; Williams TD; Miller DW; Siahaan TJ
J Pharm Sci; 2016 Feb; 105(2):797-807. PubMed ID: 26869430
[TBL] [Abstract][Full Text] [Related]
5. Improving the selectivity of HAV-peptides in modulating E-cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers.
Makagiansar IT; Avery M; Hu Y; Audus KL; Siahaan TJ
Pharm Res; 2001 Apr; 18(4):446-53. PubMed ID: 11451030
[TBL] [Abstract][Full Text] [Related]
6. Reversible Opening of Intercellular Junctions of Intestinal Epithelial and Brain Endothelial Cells With Tight Junction Modulator Peptides.
Bocsik A; Walter FR; Gyebrovszki A; Fülöp L; Blasig I; Dabrowski S; Ötvös F; Tóth A; Rákhely G; Veszelka S; Vastag M; Szabó-Révész P; Deli MA
J Pharm Sci; 2016 Feb; 105(2):754-765. PubMed ID: 26869428
[TBL] [Abstract][Full Text] [Related]
7. Brain Delivery of Drug and MRI Contrast Agent: Detection and Quantitative Determination of Brain Deposition of CPT-Glu Using LC-MS/MS and Gd-DTPA Using Magnetic Resonance Imaging.
Tabanor K; Lee P; Kiptoo P; Choi IY; Sherry EB; Eagle CS; Williams TD; Siahaan TJ
Mol Pharm; 2016 Feb; 13(2):379-90. PubMed ID: 26705088
[TBL] [Abstract][Full Text] [Related]
8. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
[TBL] [Abstract][Full Text] [Related]
9. Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors.
Sajesh BV; On NH; Omar R; Alrushaid S; Kopec BM; Wang WG; Sun HD; Lillico R; Lakowski TM; Siahaan TJ; Davies NM; Puno PT; Vanan MI; Miller DW
Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31533285
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic modeling and deconvolution of enantioselective absorption of eflornithine in the rat.
Johansson CC; Gennemark P; Artursson P; Äbelö A; Ashton M; Jansson-Löfmark R
J Pharmacokinet Pharmacodyn; 2013 Feb; 40(1):117-28. PubMed ID: 23307171
[TBL] [Abstract][Full Text] [Related]
11. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
12. Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate.
Watkins ME; Wring S; Randolph R; Park S; Powell K; Lutz L; Nowakowski M; Ramabhadran R; Domanico PL
J Pharm Sci; 2017 Mar; 106(3):906-919. PubMed ID: 27986599
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein plays a role in the oral absorption of BMS-387032, a potent cyclin-dependent kinase 2 inhibitor, in rats.
Kamath AV; Chong S; Chang M; Marathe PH
Cancer Chemother Pharmacol; 2005 Feb; 55(2):110-6. PubMed ID: 15338193
[TBL] [Abstract][Full Text] [Related]
14. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
[TBL] [Abstract][Full Text] [Related]
15.
Ulapane KR; Kopec BM; Siahaan TJ
Mol Pharm; 2019 Dec; 16(12):4878-4889. PubMed ID: 31664837
[TBL] [Abstract][Full Text] [Related]
16. Polysorbate 20 alters the oral bioavailability of etoposide in wild type and mdr1a deficient Sprague-Dawley rats.
Al-Ali AAA; Quach JRC; Bundgaard C; Steffansen B; Holm R; Nielsen CU
Int J Pharm; 2018 May; 543(1-2):352-360. PubMed ID: 29635055
[TBL] [Abstract][Full Text] [Related]
17. Identification of the primary determining factor(s) governing the oral absorption of edaravone in rats.
Hyung S; Jeong YS; Yeo J; Song YK; Kim MS; Im YJ; Maeng HJ; Chung SJ
Eur J Pharm Sci; 2018 Oct; 123():312-320. PubMed ID: 30056192
[TBL] [Abstract][Full Text] [Related]
18. Increasing paracellular porosity by E-cadherin peptides: discovery of bulge and groove regions in the EC1-domain of E-cadherin.
Sinaga E; Jois SD; Avery M; Makagiansar IT; Tambunan US; Audus KL; Siahaan TJ
Pharm Res; 2002 Aug; 19(8):1170-9. PubMed ID: 12240943
[TBL] [Abstract][Full Text] [Related]
19. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
20. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models.
Hellinger E; Veszelka S; Tóth AE; Walter F; Kittel A; Bakk ML; Tihanyi K; Háda V; Nakagawa S; Duy TD; Niwa M; Deli MA; Vastag M
Eur J Pharm Biopharm; 2012 Oct; 82(2):340-51. PubMed ID: 22906709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
